期刊文献+

创伤患者血清促红细胞生成素受体的动态变化与临床意义 被引量:2

Dynamic change of serum erythropoietin receptor and its clinical significance in trauma patients
下载PDF
导出
摘要 目的探讨创伤患者血清促红细胞生成素受体(EpoR)的动态变化规律及可能的临床意义。方法检测47例创伤患者入院后0h、24h、7d血清EpoR水平,并记录对应生理指标(白细胞、血红蛋白、血糖),同时记录所有患者急性生理与慢性健康状况评分(APACHEⅡ),损伤严重度评分(ISS)及28d预后。根据损伤类型将患者分为脑损伤组和休克组,根据28d预后将患者分为存活组和死亡组。分析血清EpoR浓度的动态变化及组间差异。同时分析患者各时间点血清EpoR浓度变化与入院后0h的ISS、APACHEⅡ评分及生理指标(白细胞、血红蛋白、血糖)的相关性。结果脑损伤组与休克组血清EpoR浓度均为24h升至高峰,7d时仍维持在显著升高水平;休克组的血清EpoR浓度在24h、7d时间点均明显高于脑损伤组;中、重度脑损伤组血清EpoR浓度在各时间点均明显升高。死亡组7d EpoR浓度仍维持较高水平;死亡组血清EpoR浓度在0h、24h、7d均显著高于存活组。血清EpoR浓度在各时间点与ISS、APACHEⅡ评分、血糖水平呈正相关,在0、24h与白细胞水平呈正相关,在7d与血红蛋白呈负相关。结论 EpoR可作为评价创伤严重程度的有效指标,可反映病情的变化趋势,对判断预后具有一定的参考价值。 Objective To explore the dynamic change of serum erythropoietin receptor and its siginificance in trauma patients.Methods The concentration of serum erythropoietin receptor in 47 trauma patients was detected at 0 h,24 h and 7 d after injury.In the meantime,white blood cell(WBC),hemoglobin,blood sugar were measured and recorded;injury severity score(ISS),Glasgow coma score(GCS),and APACHE Ⅱ at 0 h were also recorded.The patients were divided into brain injury group and shock group according to patients' injury type,and survival group and death group based on the 28 d outcome.The dynamic changes of serum erythropoietin receptor were observed and compared between the groups.The correlation of the serum erythropoietin receptor concentration with ISS,GCS,APACHE Ⅱ,WBC,hemoglobin and blood sugar was investigated.Results The serum erythropoietin receptor concentration in both shock and brain injury groups were increased after injury with the peak at 24 h,and stayed in high level at 7d.The serum erythropoietin receptor concentration in shock group was higher at 24 h and 7d compared with the brain injury group.The serum erythropoietin receptor concentration in moderate and severe brain injury groups were increased at all time points,the levels reached peak at 24 h.The serum erythropoietin receptor concentration in death group at 7 d was still high,while it was desceased in the survival group.The level in death group were higher than that in survival group at all time points.Conclusion The dynamic changes of serum erythropoietin receptor concentration in trauma patients can be used as a simple and effective marker to evaluate the severity of injury and predict the prognosis of patients.
出处 《创伤外科杂志》 2012年第3期254-257,共4页 Journal of Traumatic Surgery
关键词 创伤 脑损伤 休克 促红细胞生成素受体 trauma brain injury shock erythropoietin receptor
  • 相关文献

参考文献9

  • 1Wright GL,Hanlon P,Amin K,et al.Erythropoietin recep-tor expression in adult rat cardiomyocytes is associated withan acute cardioprotective effect for recombinant erythropoi-etin during ischemiareperfusion injury[J].FASEB J,2004,18(6):1031-1033.
  • 2Van den Berghe G,Wilmer A,Hermans G,et al.Intensiveinsulin therapy in the medical ICU[J].N Eng J Med,2006,354(5):449-461.
  • 3Zhou JH.The road crash and traffic injuries in China from2003 to 2005[J].Chin J Trauma,2008,11(1):1-5.
  • 4Liao ZB,Zhi XG,Shi QH,et al.Recombinant human eryth-ropoietin administration protects cortical neurons from trau-matic brain injury in rats[J].Eur J Neurol,2008,15(2):140-149.
  • 5Robinson LE,van Soeren MH.Insulin resistance and hy-perglycemia in critical illness:role of insulin in glycemiccontrol[J].N Eng J Med,2001,345(19):1359-1367.
  • 6Noguchi CT,Bae KS,Chin K,et al.Cloning of the humanerythropoietin receptor gene[J].Blood,1991,78(10):2548-2556.
  • 7Walrafen P,Verdier F,Kadri Z,et al.Both proteosome andlysosome degrade the activated erythropoietin receptor[J].Blood,2005,105(2):600-608.
  • 8王正国.创伤学基础与临床[M].武汉:湖北科学技术出版社,2007,1451-1454.
  • 9廖正步,支兴刚,石全红,朱继,刘北忠,钟梁.促红细胞生成素及其受体在脑外伤后的表达及意义[J].第三军医大学学报,2007,29(23):2243-2246. 被引量:6

二级参考文献10

  • 1娄季宇,曾志磊,杨霄鹏.不同剂量促红细胞生成素对大鼠脑缺血再灌注损伤后神经细胞凋亡的影响[J].郑州大学学报(医学版),2006,41(2):316-318. 被引量:27
  • 2梁淑欣,谢汉平,曾玉晓,翁传煌.重组人促红细胞生成素对大鼠视网膜缺血再灌注损伤的保护作用[J].第三军医大学学报,2006,28(17):1775-1777. 被引量:4
  • 3Marti H H. Erythropoietin and the hypoxic brain [ J ]. J Exp Biol, 2004, 207(Pt 18) : 3233 -3242.
  • 4Ruscher K, Freyer D, Karsch M, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain : evidence from an in vitro model[J]. J Neurosci, 2002, 22(23) : 10291 - 10301.
  • 5Jelkmann W. Effects of erythropoietin on brain function [ J ]. Curr Pharm Biotechnol, 2005, 6( 1 ) : 65 -79.
  • 6Kilic E, Kilic U, Soliz J, et al. Brain-derived erythropoietin protects from focal cerebral isehemia by dual activation of ERK-1/-2 and Akt pathways[J]. FASEB J, 2005, 19(14) : 2026 -2028.
  • 7Sun Y, Calvert J W, Zhang J H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration[J]. Stroke, 2005, 36(8) : 1672 - 1678.
  • 8von-Wussow U, Klaus J, Pagel H. Is the renal production of erythropoietin controlled by the brain stem? [ J ]. Am J Physiol Endocrinol Metab, 2005, 289( 1 ) : E82 - E86.
  • 9Buemi M, Cavallaro E, Floccari F, et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection [ J ]. Clin Sci (Lond), 2002, 103(3): 275-282.
  • 10Gocht D, Sargin D, Sperling S, et al. Expression and function of erythropoietin and its receptor in invertebrate nervous systems [ C ]. G ttingen: G ttingen Meeting of the German Neuroscience Society, 2007, T3-6A.

共引文献30

同被引文献30

  • 1王艳,王海霞,马希刚.重症患者凝血指标对病情及预后的评价作用[J].宁夏医科大学学报,2013,35(9):980-983. 被引量:9
  • 2DE LIMA GA, MAZZALI M, GENTIL AF, et al. Anemia in chronic renal disease: evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment[ J]. Clin Lab, 2012, 58(7-8) :695-704.
  • 3CAO Y, LATHIA JD, EYLER CE, et al. Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance [ J ]. Genes Cancer, 2010,1 ( 1 ) :50-61.
  • 4BACKER V, SCHILLING M, BACHMANN J, et al. Covering a broad dynamic range : information processing at the erythropoietin receptor [ J ]. Science, 2010, 328 (5984) : 1404-1408.
  • 5CAMMETT TJ, JUN SJ, COHEN EB, et al. Construction and genetic selection of small transmembrane proteins that activate the human erythropoietin receptor[ J]. Proc Natl Acad Sci USA, 2010, 107(8) :3447-3452.
  • 6SINCLAIR AM, COXON A, MCCAFFEY I, et al. Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells [ J ]. Blood, 2010, 115(21) :4264-4272.
  • 7KHANKIN EV, MUTTER WP, TAMEZ H, et al. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease [J]. PLoS One, 2010,5(2) :e9246.
  • 8NALBANT D, SALEH M, GOLDMAN FD, et al. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia [ J ]. J Pharmacol Exp Ther, 2010, 333(2) :528-532.
  • 9BRUGNIAUX JV, PIALOUX V, FOSTER GE, et al. Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans [ J 1. Eur Respir J, 2011, 37 (4) : 880-887.
  • 10DO SAMEIRO-FARIA M, RIBEIRO S, ROCHA- PEREIRA P, et al. Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients [ J ]. Ren Fail, 2013, 35 (10): 1392-1398.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部